Trillium Therapeutics Inc. (TRIL) NASDAQ

$18.44 0 (0.00%)

Market Cap: $0

As of 11/16/21 12:00 AM EST. Market closed.

(TRIL)

Trillium Therapeutics Inc. (TRIL) NASDAQ

$18.44 0 (0.00%)

Market Cap: $0

As of 11/16/21 12:00 AM EST. Market closed.

Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s two clinical programs, TTI-621 and TTI-622, target CD47, a “don’t eat me” signal that cancer cells frequently use to evade the immune ... read more

Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s two clinical programs, TTI-621 and TTI-622, target CD47, a “don’t eat me” signal that cancer cells frequently use to evade the immune system. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
33
Address
.
KEY STATS
Open
$18.45
Previous Close
$18.44
Days Range
$17.83 - $18.49
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
104,995,125
Open
$18.45
Previous Close
$18.44
Days Range
$17.83 - $18.49
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
104,995,125

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TRILLIUM THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Uger Robert Chief Scientific Officer Jul 07, 2021 Option Exercise $0.30 3,646 1,108 3,646 Jul 09, 2021, 04:30 PM
Uger Robert Chief Scientific Officer Jul 07, 2021 Sale $9.00 3,646 32,814 0 Jul 09, 2021, 04:30 PM
Uger Robert Chief Scientific Officer Apr 07, 2021 Option Exercise $0.30 3,646 1,098 3,646 Apr 09, 2021, 05:38 PM
Uger Robert Chief Scientific Officer Apr 07, 2021 Sale $10.82 3,646 39,450 0 Apr 09, 2021, 05:38 PM
Petrova Penka Chief Development Officer Apr 08, 2021 Option Exercise $1.80 5,312 9,578 5,312 Apr 09, 2021, 05:23 PM
Petrova Penka Chief Development Officer Apr 08, 2021 Sale $11.09 5,312 58,910 0 Apr 09, 2021, 05:23 PM
Uger Robert Chief Scientific Officer Mar 12, 2021 Option Exercise $3.39 2,917 9,896 2,917 Mar 15, 2021, 05:12 PM
Uger Robert Chief Scientific Officer Mar 12, 2021 Sale $11.97 2,917 34,916 0 Mar 15, 2021, 05:12 PM
Petrova Penka Chief Development Officer Mar 10, 2021 Option Exercise $1.80 5,312 9,545 5,312 Mar 12, 2021, 04:40 PM
Petrova Penka Chief Development Officer Mar 10, 2021 Sale $11.08 5,312 58,857 0 Mar 12, 2021, 04:40 PM
Uger Robert Chief Scientific Officer Mar 08, 2021 Option Exercise $0.30 3,646 1,093 3,646 Mar 10, 2021, 05:57 PM
Uger Robert Chief Scientific Officer Mar 08, 2021 Sale $10.11 3,646 36,861 0 Mar 10, 2021, 05:57 PM
Petrova Penka Chief Development Officer Feb 08, 2021 Option Exercise $1.78 5,312 9,435 5,312 Feb 10, 2021, 07:18 PM
Petrova Penka Chief Development Officer Feb 09, 2021 Option Exercise $9.62 508 4,888 508 Feb 10, 2021, 07:18 PM
Petrova Penka Chief Development Officer Feb 08, 2021 Sale $12.65 5,312 67,197 0 Feb 10, 2021, 07:18 PM
Petrova Penka Chief Development Officer Feb 09, 2021 Sale $14.17 508 7,200 0 Feb 10, 2021, 07:18 PM
Uger Robert Chief Scientific Officer Feb 08, 2021 Option Exercise $1.64 6,563 10,751 6,563 Feb 10, 2021, 07:18 PM
Uger Robert Chief Scientific Officer Feb 09, 2021 Option Exercise $9.62 584 5,619 584 Feb 10, 2021, 07:18 PM
Uger Robert Chief Scientific Officer Feb 08, 2021 Sale $12.65 6,563 83,022 0 Feb 10, 2021, 07:18 PM
Uger Robert Chief Scientific Officer Feb 09, 2021 Sale $14.12 584 8,248 0 Feb 10, 2021, 07:18 PM
Skvarka Jan President and CEO Jan 13, 2021 Option Exercise $0.42 5,419 2,302 5,419 Jan 15, 2021, 04:19 PM
Skvarka Jan President and CEO Jan 14, 2021 Option Exercise $0.43 19,581 8,371 19,581 Jan 15, 2021, 04:19 PM
Skvarka Jan President and CEO Jan 13, 2021 Sale $15.04 5,419 81,508 0 Jan 15, 2021, 04:19 PM
Skvarka Jan President and CEO Jan 14, 2021 Sale $15.03 19,581 294,279 0 Jan 15, 2021, 04:19 PM
Uger Robert Chief Scientific Officer Jan 11, 2021 Option Exercise $9.57 584 5,587 584 Jan 13, 2021, 04:12 PM
Uger Robert Chief Scientific Officer Jan 11, 2021 Sale $15.20 584 8,879 0 Jan 13, 2021, 04:12 PM
Petrova Penka Chief Development Officer Jan 11, 2021 Option Exercise $9.57 508 4,860 508 Jan 13, 2021, 04:11 PM
Petrova Penka Chief Development Officer Jan 11, 2021 Sale $15.21 508 7,725 0 Jan 13, 2021, 04:11 PM
Parsons James T. Chief Financial Officer Jan 08, 2021 Option Exercise $7.24 8,505 61,616 8,505 Jan 12, 2021, 04:12 PM
Parsons James T. Chief Financial Officer Jan 08, 2021 Sale $15.79 8,505 134,271 0 Jan 12, 2021, 04:12 PM
Uger Robert Chief Scientific Officer Jan 08, 2021 Option Exercise $8.38 8,517 71,365 5,600 Jan 12, 2021, 04:11 PM
Uger Robert Chief Scientific Officer Jan 08, 2021 Sale $15.71 8,517 133,806 0 Jan 12, 2021, 04:11 PM
Petrova Penka Chief Development Officer Jan 08, 2021 Option Exercise $3.33 2,604 8,674 2,604 Jan 12, 2021, 04:10 PM
Petrova Penka Chief Development Officer Jan 08, 2021 Sale $15.50 2,604 40,365 0 Jan 12, 2021, 04:10 PM
Petrova Penka Chief Development Officer Jan 07, 2021 Option Exercise $0.30 2,708 809 2,708 Jan 11, 2021, 04:19 PM
Petrova Penka Chief Development Officer Jan 07, 2021 Sale $14.71 2,708 39,843 0 Jan 11, 2021, 04:19 PM
Uger Robert Chief Scientific Officer Jan 07, 2021 Option Exercise $0.30 3,646 1,089 3,646 Jan 11, 2021, 04:17 PM
Uger Robert Chief Scientific Officer Jan 07, 2021 Sale $14.75 3,646 53,782 0 Jan 11, 2021, 04:17 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Uger Robert Chief Scientific Officer 07/07/2021 1,108
Uger Robert Chief Scientific Officer 07/07/2021 32,814
Uger Robert Chief Scientific Officer 04/07/2021 1,098
Uger Robert Chief Scientific Officer 04/07/2021 39,450
Petrova Penka Chief Development Officer 04/08/2021 9,578
Petrova Penka Chief Development Officer 04/08/2021 58,910
Uger Robert Chief Scientific Officer 03/12/2021 9,896
Uger Robert Chief Scientific Officer 03/12/2021 34,916
Petrova Penka Chief Development Officer 03/10/2021 9,545
Petrova Penka Chief Development Officer 03/10/2021 58,857
Uger Robert Chief Scientific Officer 03/08/2021 1,093
Uger Robert Chief Scientific Officer 03/08/2021 36,861
Petrova Penka Chief Development Officer 02/08/2021 9,435
Petrova Penka Chief Development Officer 02/09/2021 4,888
Petrova Penka Chief Development Officer 02/08/2021 67,197
Petrova Penka Chief Development Officer 02/09/2021 7,200
Uger Robert Chief Scientific Officer 02/08/2021 10,751
Uger Robert Chief Scientific Officer 02/09/2021 5,619
Uger Robert Chief Scientific Officer 02/08/2021 83,022
Uger Robert Chief Scientific Officer 02/09/2021 8,248
Skvarka Jan President and CEO 01/13/2021 2,302
Skvarka Jan President and CEO 01/14/2021 8,371
Skvarka Jan President and CEO 01/13/2021 81,508
Skvarka Jan President and CEO 01/14/2021 294,279
Uger Robert Chief Scientific Officer 01/11/2021 5,587
Uger Robert Chief Scientific Officer 01/11/2021 8,879
Petrova Penka Chief Development Officer 01/11/2021 4,860
Petrova Penka Chief Development Officer 01/11/2021 7,725
Parsons James T. Chief Financial Officer 01/08/2021 61,616
Parsons James T. Chief Financial Officer 01/08/2021 134,271
Uger Robert Chief Scientific Officer 01/08/2021 71,365
Uger Robert Chief Scientific Officer 01/08/2021 133,806
Petrova Penka Chief Development Officer 01/08/2021 8,674
Petrova Penka Chief Development Officer 01/08/2021 40,365
Petrova Penka Chief Development Officer 01/07/2021 809
Petrova Penka Chief Development Officer 01/07/2021 39,843
Uger Robert Chief Scientific Officer 01/07/2021 1,089
Uger Robert Chief Scientific Officer 01/07/2021 53,782
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
0.48%
1Q
09/30/2021
03/31/2021
0.86%
2Q
09/30/2021
12/31/2020
22.80%
3Q

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
0.48%
1Q
03/31/2021
0.86%
2Q
12/31/2020
22.80%
3Q